Literature DB >> 25003745

Budd-Chiari syndrome in children: clinical features, percutaneous radiological intervention, and outcome.

Rachana Kathuria1, Anshu Srivastava, Surender K Yachha, Ujjal Poddar, Sanjay S Baijal.   

Abstract

OBJECTIVES: 'Radiological intervention' to restore venous patency is the preferred therapy in adults with Budd-Chiari syndrome (BCS). The published literature on pediatric BCS is scarce. This study evaluated the clinical profile and role of a therapeutic radiological intervention in children with BCS. PATIENTS AND METHODS: Forty-six BCS children [29 boys, median age 10.5 (2-16) years] were enrolled. Standard medical therapy was administered to all. A radiological intervention, angioplasty [hepatic vein (HV) (n=3)], stenting [HV (n=18), inferior vena cava (IVC) (n=5)], transjugular intrahepatic portosystemic shunt (TIPS) (n=3), was performed in 25 cases. Clinical, biochemical, and radiological follow-up was carried out.
RESULTS: Doppler ultrasonography was diagnostic in 95% of cases. All patients had chronic BCS, with ascites in 82.6%, hepatomegaly in 84.8%, splenomegaly in 69.6%, prominent abdominal veins in 69.6%, and variceal bleed in 34.8% cases. The most common site of block was HV (n=33), followed by combined HV and IVC block (n=11), and isolated IVC block (n=2). Eight of 12 (75%) cases had abnormal procoagulant workup. Radiological intervention was technically successful in 100%. Clinical and biochemical improvement was observed in the intervention group. Complications included neck hematoma and hemorrhagic ascites in one patient each. One child in the intervention group (post-TIPS sudden cardiac event) and two children in the nonintervention group [end-stage liver disease (n=1), head injury (n=1)] died. Stent was patent in 15/20 (75%) children over a median follow-up of 6.5 months.
CONCLUSION: HV block and a chronic presentation are most common in BCS children. Doppler ultrasonography establishes the diagnosis in 95% of cases. Radiological intervention is an effective and safe therapeutic modality for children with BCS.

Entities:  

Mesh:

Year:  2014        PMID: 25003745     DOI: 10.1097/MEG.0000000000000144

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  9 in total

1.  Budd-Chiari syndrome has different presentations and disease severity during adolescence.

Authors:  Akash Shukla; Pratin Bhatt; Deepak Kumar Gupta; Tejas Modi; Jatin Patel; Amit Gupte; Megha Meshram; Shobna Bhatia
Journal:  Hepatol Int       Date:  2018-07-03       Impact factor: 6.047

2.  Liver Transplantation and Budd-Chiari Syndrome: When the Cause Becomes the Solution.

Authors:  Nikolaos Garmpis; Christos Damaskos; Dionysios Prevezanos; Anna Garmpi; Vasiliki E Georgakopoulou; Efstathios A Antoniou; Gregory Kouraklis; Dimitrios Dimitroulis
Journal:  Maedica (Bucur)       Date:  2022-06

3.  Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Akash Shukla; Ananta Shreshtha; Amar Mukund; Chhagan Bihari; C E Eapen; Guohong Han; Hemant Deshmukh; Ian Homer Y Cua; Cosmas Rinaldi Adithya Lesmana; Mamun Al Meshtab; Masayoshi Kage; Roongruedee Chaiteeraki; Sombat Treeprasertsuk; Suprabhat Giri; Sundeep Punamiya; Valerie Paradis; Xingshun Qi; Yasuhiko Sugawara; Zaigham Abbas; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-07-08       Impact factor: 6.047

Review 4.  Splenomegaly in Children and Adolescents.

Authors:  Meinolf Suttorp; Carl Friedrich Classen
Journal:  Front Pediatr       Date:  2021-07-09       Impact factor: 3.418

Review 5.  Thrombosis of the Abdominal Veins in Childhood.

Authors:  Riten Kumar; Bryce A Kerlin
Journal:  Front Pediatr       Date:  2017-09-05       Impact factor: 3.418

6.  Outcome of radiological interventions in pediatric gastrointestinal diseases: A large tertiary center experience.

Authors:  Zaheer Nabi; Jagadeesh R Singh; Arafat Haris; Upender Shava; Radhika Chavan; Duvvur Nageshwar Reddy
Journal:  JGH Open       Date:  2018-12-27

7.  Clinicohistological correlation of etiological spectrum of chronic liver disease diagnosed during noncirrhotic stages in children: Can need of liver biopsy be obviated?

Authors:  Tryambak Samanta; Rajarshi Basu; Radheshyam Purkait; Sudipta Kar; Debasis Das; Sutapa Ganguly
Journal:  JGH Open       Date:  2020-10-30

8.  Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis.

Authors:  Gauri Mukhiya; Xueliang Zhou; Xinwei Han; Dechao Jiao; Gaurab Pokhrel; Yahua Li; Sita Pokhrel
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

Review 9.  An Update on the Management of Budd-Chiari Syndrome.

Authors:  A Sharma; S N Keshava; A Eapen; E Elias; C E Eapen
Journal:  Dig Dis Sci       Date:  2020-07-20       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.